grant
CoMTAD: Cognitive Monitoring during Treatment for Alzheimer disease
Organization UNIVERSITY OF KANSAS MEDICAL CENTERLocation KANSAS CITY, UNITED STATESPosted 1 Feb 2026Deadline 31 Dec 2030
NIHUS FederalResearch GrantFY2026AD dementiaAD therapyAD treatmentAccess to CareAcuteAddressAdverse ExperienceAdverse eventAfter CareAfter-TreatmentAftercareAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer disease treatmentAlzheimer sclerosisAlzheimer syndromeAlzheimer treatmentAlzheimer'sAlzheimer's DiseaseAlzheimer's disease therapeuticAlzheimer's disease therapyAlzheimer's therapeuticAlzheimer's therapyAlzheimers DementiaAmyloidAmyloid (Aβ) plaquesAmyloid PlaquesAmyloid SubstanceAndroid AppAndroid ApplicationBenchmarkingBest Practice AnalysisCare GiversCaregiversCell PhoneCell Phone ApplicationCell phone AppCellular PhoneCellular Phone AppCellular Phone ApplicationCellular TelephoneCephalalgiaCephalgiaCephalodyniaCerebrospinal FluidClassificationClinicClinicalClinical TrialsCognitionCognitiveCognitive DisturbanceCognitive ImpairmentCognitive declineCognitive function abnormalConfusionConfusional StateCranial PainDataDecision MakingDegenerative Neurologic DisordersDevelopmentDisturbance in cognitionDizzinessDoseDropsDropsyDrug TherapyDrugsEdemaEligibilityEligibility DeterminationEnrollmentEnsureEventFrequenciesGeneral PopulationGeneral PublicGoalsGuidelinesHead PainHeadacheHealthHealth Services AccessibilityHospital AdmissionHospitalizationHourHydropsImageImmune mediated therapyImmunologically Directed TherapyImmunotherapyImpaired cognitionIncidenceIndividualInfrastructureLeadLifeMR ImagingMR TomographyMRIMRI ScansMRIsMagnetic Resonance ImagingMagnetic Resonance Imaging ScanMedicalMedical Imaging, Magnetic Resonance / Nuclear Magnetic ResonanceMedical centerMedicationMental ConfusionMethodsMobile PhonesModelingMonitorNMR ImagingNMR TomographyNervous System Degenerative DiseasesNeural Degenerative DiseasesNeural degenerative DisordersNeuritic PlaquesNeurodegenerative DiseasesNeurodegenerative DisordersNeurofibrillary TanglesNeurologicNeurologic Degenerative ConditionsNeurologicalNeuropsychologic TestsNeuropsychological TestsNuclear Magnetic Resonance ImagingParticipantPatient Monitoring SystemPatientsPb elementPerformancePharmaceutical PreparationsPharmacological TreatmentPharmacotherapyPhysiciansPopulationPrimary Senile Degenerative DementiaProbabilistic ModelsProbability ModelsProtocol ScreeningProviderReaction TimeRecommendationReportingResearchResponse RTResponse TimeRiskSafetyScanningScheduleSenile PlaquesSleepSleep DeprivationSmart Phone AppSmart Phone ApplicationSmartphone AppStatistical ModelsSymptomsSystemSystematicsTestingTimeTitrationsVariantVariationVolunteer GroupZeugmatographyaccess to health servicesaccess to servicesaccess to treatmentaccessibility to health servicesadverse consequenceadverse outcomeamyloid beta plaqueamyloid-b plaqueapp on a smartphoneapplication on a smartphoneavailability of servicesaβ plaquesbenchmarkblood-based biomarkerblood-based markercare accesscell phone based appcerebral spinal fluidclinical decision-makingcognitive assessmentcognitive changecognitive dysfunctioncognitive losscognitive testingcored plaquecostcost effectivedeficient sleepdegenerative diseases of motor and sensory neuronsdegenerative neurological diseasesdesigndesigningdevelopmentaldiffuse plaquedigitaldigital cognitive assessmentdigital cognitive testdrug interventiondrug safetydrug treatmentdrug/agentenrollfightinghead achehealth service accesshealth services availabilityhealthy volunteerheavy metal Pbheavy metal leadiOS appiOS applicationiPhoneiPhone AppiPhone Applicationimagingimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyinadequate sleepinstrumentinsufficient sleepmedication safetymobile phone appneurodegenerative illnessneurofibrillary degenerationneurofibrillary lesionneurofibrillary pathologynew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyolder adultolder adulthoodonline apppharmaceutical interventionpharmaceutical safetypharmacological interventionpharmacological therapypharmacology interventionpharmacology treatmentpharmacotherapeuticsphone appphone applicationpost treatmentprimary degenerative dementiapsychomotor reaction timeremote administrationsenile dementia of the Alzheimer typeservice availabilityside effectsleep debtsleep deficiencysleep deficitsleep insufficiencysleep losssmart phonesmartphonesmartphone applicationsmartphone based appsmartphone based applicationspinal fluidstatistical linear mixed modelsstatistical linear modelstangletooltreatment accessweb appweb applicationweb based appweb based application
Description preview
PROJECT SUMMARY
There are now anti-amyloid therapies available to slow the clinical progression of Alzheimer’s disease (AD).
These therapies come with the risk of negative side-effects including amyloid related imaging abnormalities
(ARIA). Little is known about acute and long-term cognitive consequences of ARIA events given the expense
and staff…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click